116 related articles for article (PubMed ID: 38588595)
1. The role of Matrix Metalloproteinase-2 and Galectin-3 as predictive biomarkers for all-cause mortality in patients undergoing transfemoral transcatheter aortic valve implantation.
Piayda K; Heilemann JT; Keranov S; Schulz L; Arsalan M; Liebetrau C; Kim WK; Hofmann FJ; Bauer P; Voss S; Troidl C; Sossalla ST; Hamm CW; Nef HM; Dörr O
Biomarkers; 2024 Jun; 29(4):205-210. PubMed ID: 38588595
[TBL] [Abstract][Full Text] [Related]
2. Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.
Rheude T; Pellegrini C; Núñez J; Joner M; Trenkwalder T; Mayr NP; Holdenrieder S; Bodi V; Koenig W; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C; Husser O
Rev Esp Cardiol (Engl Ed); 2019 Nov; 72(11):907-915. PubMed ID: 30482731
[TBL] [Abstract][Full Text] [Related]
3. Insulin like growth factor binding protein 2 (IGFBP-2) for risk prediction in patients with severe aortic stenosis undergoing Transcatheter Aortic Valve Implantation (TAVI).
Muessig JM; Lichtenauer M; Wernly B; Kelm M; Franz M; Bäz L; Schulze PC; Racher V; Zimmermann G; Figulla HR; Paar V; Hoppe UC; Rouet P; Lauten A; Jung C
Int J Cardiol; 2019 Feb; 277():54-59. PubMed ID: 30309683
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 predicts short- and long-term outcome in patients undergoing transcatheter aortic valve implantation (TAVI).
Baldenhofer G; Zhang K; Spethmann S; Laule M; Eilers B; Leonhardt F; Sanad W; Dreger H; Sander M; Grubitzsch H; Baumann G; Stangl K; Stangl V; Knebel F
Int J Cardiol; 2014 Dec; 177(3):912-7. PubMed ID: 25456698
[TBL] [Abstract][Full Text] [Related]
5. ST2 predicts survival in patients undergoing transcatheter aortic valve implantation.
Schmid J; Stojakovic T; Zweiker D; Scharnagl H; Maderthaner RD; Scherr D; Maier R; Schmidt A; März W; Binder JS; Rainer PP
Int J Cardiol; 2017 Oct; 244():87-92. PubMed ID: 28651919
[TBL] [Abstract][Full Text] [Related]
6. Elevated growth differentiation factor 15 levels predict outcome in patients undergoing transcatheter aortic valve implantation.
Krau NC; Lünstedt NS; Freitag-Wolf S; Brehm D; Petzina R; Lutter G; Bramlage P; Dempfle A; Frey N; Frank D
Eur J Heart Fail; 2015 Sep; 17(9):945-55. PubMed ID: 26230285
[TBL] [Abstract][Full Text] [Related]
7. Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized Transcatheter Valvular Intervention-Transcatheter Aortic Valve Implantation) Registry.
Mizutani K; Hara M; Iwata S; Murakami T; Shibata T; Yoshiyama M; Naganuma T; Yamanaka F; Higashimori A; Tada N; Takagi K; Araki M; Ueno H; Tabata M; Shirai S; Watanabe Y; Yamamoto M; Hayashida K
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28710182
[TBL] [Abstract][Full Text] [Related]
8. Deceleration capacity of heart rate predicts 1-year mortality of patients undergoing transcatheter aortic valve implantation.
Duckheim M; Bensch C; Kittlitz L; Götz N; Klee K; Groga-Bada P; Mizera L; Gawaz M; Zuern C; Eick C
Clin Cardiol; 2017 Oct; 40(10):919-924. PubMed ID: 28846802
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell distribution width as a prognostic factor in patients undergoing transcatheter aortic valve implantation.
Szekely Y; Finkelstein A; Bazan S; Halkin A; Abbas Younis M; Erez J; Keren G; Banai S; Arbel Y
J Cardiol; 2019 Sep; 74(3):212-216. PubMed ID: 31060955
[TBL] [Abstract][Full Text] [Related]
10. Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.
Zahn R; Werner N; Gerckens U; Linke A; Sievert H; Kahlert P; Hambrecht R; Sack S; Abdel-Wahab M; Hoffmann E; Zeymer U; Schneider S;
Heart; 2017 Dec; 103(24):1970-1976. PubMed ID: 28684438
[TBL] [Abstract][Full Text] [Related]
11. EuroSCORE II and the STS score are more accurate in transapical than in transfemoral transcatheter aortic valve implantation.
Kofler M; Reinstadler SJ; Stastny L; Dumfarth J; Reindl M; Wachter K; Rustenbach CJ; Müller S; Feuchtner G; Friedrich G; Metzler B; Grimm M; Bonaros N; Baumbach H
Interact Cardiovasc Thorac Surg; 2018 Mar; 26(3):413-419. PubMed ID: 29088475
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory signatures are associated with increased mortality after transfemoral transcatheter aortic valve implantation.
Hoffmann J; Mas-Peiro S; Berkowitsch A; Boeckling F; Rasper T; Pieszko K; De Rosa R; Hiczkiewicz J; Burchardt P; Fichtlscherer S; Zeiher AM; Dimmeler S; Nicotera MV
ESC Heart Fail; 2020 Oct; 7(5):2597-2610. PubMed ID: 32639677
[TBL] [Abstract][Full Text] [Related]
13. Clinical Correlates and Prognostic Value of Plasma Galectin-3 Levels in Degenerative Aortic Stenosis: A Single-Center Prospective Study of Patients Referred for Invasive Treatment.
Bobrowska B; Wieczorek-Surdacka E; Kruszelnicka O; Chyrchel B; Surdacki A; Dudek D
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468272
[TBL] [Abstract][Full Text] [Related]
14. Prognostic utility of biomarkers in predicting of one-year outcomes in patients with aortic stenosis treated with transcatheter or surgical aortic valve implantation.
Parenica J; Nemec P; Tomandl J; Ondrasek J; Pavkova-Goldbergova M; Tretina M; Jarkovsky J; Littnerova S; Poloczek M; Pokorny P; Spinar J; Cermakova Z; Miklik R; Malik P; Pes O; Lipkova J; Tomandlova M; Kala P
PLoS One; 2012; 7(12):e48851. PubMed ID: 23272045
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the choice between transcatheter and surgical treatment of severe aortic stenosis in patients younger than 80 years: Results from the OBSERVANT study.
Tarantini G; Nai Fovino L; D'Errigo P; Rosato S; Barbanti M; Tamburino C; Ranucci M; Santoro G; Badoni G; Seccareccia F;
Catheter Cardiovasc Interv; 2020 May; 95(6):E186-E195. PubMed ID: 31423704
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of preprocedural procalcitonin for short- and long-term mortality after transfemoral transcatheter aortic valve implantation.
Keranov S; Kim WK; Arsalan M; Renker M; Keller T; Bauer T; Dörr O; Nef HM; Gaede L; Möllmann H; Walther T; Hamm CW; Liebetrau C
Heart Vessels; 2019 Dec; 34(12):1993-2001. PubMed ID: 31175405
[TBL] [Abstract][Full Text] [Related]
17. EuroSCORE II and STS as mortality predictors in patients undergoing TAVI.
Rosa VE; Lopes AS; Accorsi TA; Fernandes JR; Spina GS; Sampaio RO; Paixão MR; Pomerantzeff PM; Lemos Neto PA; Tarasoutchi F
Rev Assoc Med Bras (1992); 2016; 62(1):32-7. PubMed ID: 27008490
[TBL] [Abstract][Full Text] [Related]
18. Association between valvuloarterial impedance after transcatheter aortic valve implantation and 2-year mortality in elderly patients with severe symptomatic aortic stenosis: the OCEAN-TAVI registry.
Nagura F; Kataoka A; Hara M; Kozuma K; Watanabe Y; Nakashima M; Hioki H; Kawashima H; Nara Y; Shirai S; Tada N; Araki M; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Higashimori A; Takagi K; Yamamoto M; Hayashida K;
Heart Vessels; 2019 Jun; 34(6):1031-1039. PubMed ID: 30599060
[TBL] [Abstract][Full Text] [Related]
19. Baseline NT-proBNP Accurately Predicts Symptom Response to Transcatheter Aortic Valve Implantation.
Allen CJ; Joseph J; Patterson T; Hammond-Haley M; McConkey HZR; Prendergast BD; Marber M; Redwood SR
J Am Heart Assoc; 2020 Dec; 9(23):e017574. PubMed ID: 33241754
[TBL] [Abstract][Full Text] [Related]
20. Soluble ST2 for Risk Stratification and the Prediction of Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation.
Stundl A; Lünstedt NS; Courtz F; Freitag-Wolf S; Frey N; Holdenrieder S; Zur B; Grube E; Nickenig G; Werner N; Frank D; Sinning JM
Am J Cardiol; 2017 Sep; 120(6):986-993. PubMed ID: 28739033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
